MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Shows Differential Brain Activation vs. Liraglutide in Mice

被引：0
|
作者：
Burke, Luke K.
Brown, Lee
Lapointe, Jean-Martin
Sulikowski, Michal Grzegorz
Lewis, Arthur R.
Trevaskis, James
Baker, David
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1789-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] MEDI0382, a GLP-1/glucagon receptor dual agonist, improves NASH and reduces liver fibrosis in mice
    Trevaskis, J. L.
    Boland, M. L.
    Conway, J.
    Guionaud, S.
    Grimsby, J.
    Jermutus, L.
    Rhodes, C. J.
    DIABETOLOGIA, 2018, 61 : S590 - S590
  • [2] Acute Metabolic Effects of MEDI0382, a GLP-1/Glucagon Dual Agonist, in Wild Type and GLP-1 Receptor Knockout (GLP-1RKO) Mice
    Will, Sarah E.
    Naylor, Jacqueline
    Rossi, Alessandra
    Hornigold, David
    Oldham, Stephanie
    Trevaskis, James
    Konkar, Anish
    DIABETES, 2016, 65 : A35 - A35
  • [3] MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Dramatically Reduces Hepatic Collagen in a Mouse Model of NASH
    Beaton, Michelle
    Guionaud, Silvia
    Conway, James P.
    Grimsby, Joe
    Rhodes, Christopher J.
    Jermutus, Lutz
    Trevaskis, James
    DIABETES, 2019, 68
  • [4] MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, Dramatically Reduces Hepatic Collagen in a Mouse Model of NASH
    Beaton, Michelle
    Guionaud, Silvia
    Conway, James P.
    Grimsby, Joe
    Rhodes, Christopher J.
    Jermutus, Lutz
    Trevaskis, James
    DIABETES, 2018, 67
  • [5] The Dual Glucagon-Like Peptide-1 (GLP-1)/Glucagon Receptor Agonist MEDI0382 Improves Metabolic and Hepatic Indices of NASH in Mice
    Trevaskis, James
    Beaton, Michelle L.
    Bednarek, Maria
    Hornigold, David C.
    Naylor, Jacqui
    Collinson, Andie
    Veidal, Sanne Skovgaard
    Madsen, Andreas Nygaard
    Ambery, Philip
    Henderson, Simon
    Coghlan, Matthew P.
    Grimsby, Joseph
    Rhodes, Christopher
    Jermutus, Lutz
    Konkar, Anish
    HEPATOLOGY, 2016, 64 : 751A - 751A
  • [6] Medi0382, a GLP-1/glucagon receptor dual agonist, reduces weight and improves metabolism via central and peripheral actions
    Baker, D.
    Oldham, S.
    Will, S.
    Church, C.
    Davies, G.
    Burke, L.
    Brown, L.
    Sulikowski, M.
    Lapointe, J. -M.
    Lewis, A.
    Jouihan, H.
    Barkholt, P.
    Gronlund, R. Veggerby
    Rhodes, C.
    Trevaskis, J.
    DIABETOLOGIA, 2018, 61 : S292 - S292
  • [7] Evaluating the Sub-chronic Effects of MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, on Weight Loss in Male ob/ob Mice
    Oldham, Stephanie
    Church, Christopher D.
    Will, Sarah
    Konkar, Anish
    Trevaskis, James
    Davies, Graeme R.
    DIABETES, 2018, 67
  • [8] MEDI0382, a dual GLP-1/glucagon receptor agonist, exerts beneficial effects on mitochondrial content and function in primary hepatocytes from lean and NASH mice
    Beaton, Michelle L.
    Grimsby, Joseph
    Rhodes, Christopher
    Jermutus, Lutz
    Konkar, Anish
    Trevaskis, James
    HEPATOLOGY, 2016, 64 : 787A - 787A
  • [9] MEDI0382, a GLP-1/Glucagon Receptor Dual Agonist, in Patients with Type 2 Diabetes-A Multiple-Ascending-Dose Study
    Robertson, Darren
    Stumvoll, Michael W.
    Posch, Maximilian G.
    Heise, Tim
    Plum-Moerschel, Leona
    Klein, Gernot
    Tsai, Lan-Feng
    Petrone, Marcella
    Hirshberg, Boaz
    Rondinone, Cristina
    Parker, Victoria E.
    Jermutus, Lutz
    Ambery, Philip
    DIABETES, 2018, 67
  • [10] MEDI0382, a dual GLP-1 glucagon receptor agonist, promotes rapid glucose control and significant weight loss in patients with type 2 diabetes
    Parker, V.
    Ambery, P.
    Robertson, D.
    Posch, M.
    Plum-Moerschel, L.
    Wang, T.
    Petrone, M.
    Heise, T.
    Meier, J.
    Hirshberg, B.
    DIABETOLOGIA, 2018, 61 : S84 - S84
12345